These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12795833)

  • 41. Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib.
    Wahl K; Siegemund M; Lehner F; Vondran F; Nüssler A; Länger F; Krech T; Kontermann R; Manns MP; Schulze-Osthoff K; Pfizenmaier K; Bantel H
    Hepatology; 2013 Feb; 57(2):625-36. PubMed ID: 22991197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
    Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3.
    Chen KF; Tai WT; Liu TH; Huang HP; Lin YC; Shiau CW; Li PK; Chen PJ; Cheng AL
    Clin Cancer Res; 2010 Nov; 16(21):5189-99. PubMed ID: 20884624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-human hepatocellular carcinoma effects of tumor necrosis factor-related apoptosis-inducing ligand in vitro & in vivo.
    Guo BC; Xu YH
    Acta Pharmacol Sin; 2001 Sep; 22(9):831-6. PubMed ID: 11749866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
    Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apoptosis-related factors (TRAIL, DR4, DR5, DcR1, DcR2, apoptotic cells) and proliferative activity in ameloblastomas.
    Rizzardi C; Leocata P; Ventura L; Zweyer M; Brollo A; Schneider M; Melato M
    Anticancer Res; 2009 Apr; 29(4):1137-42. PubMed ID: 19414356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Synergistic lethal effect of mDRA-6 and nimesulide on human hepatocellular cancer cell line SMMC-7721].
    Liu YJ; Ma YF; Zhang J; Zhao YP; Bai HL; Li SL
    Ai Zheng; 2008 Apr; 27(4):374-8. PubMed ID: 18423123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different apoptotic regulation of TRAIL-caspase pathway in HBV- and HCV-related hepatocellular carcinoma.
    Yano Y; Hayashi Y; Nakaji M; Nagano H; Seo Y; Ninomiya T; Yoon S; Wada A; Hirai M; Kim SR; Yokozaki H; Kasuga M
    Int J Mol Med; 2003 Apr; 11(4):499-504. PubMed ID: 12632104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epigallocatechin-3-gallate induces apoptosis in human hepatocellular carcinoma cells].
    Chen XL; Wang Q; Cao LQ; Huang XH; Fu XH; Tan HX; Zhen MC; Chen JS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2524-8. PubMed ID: 19080641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation.
    Carlisi D; Lauricella M; D'Anneo A; Emanuele S; Angileri L; Di Fazio P; Santulli A; Vento R; Tesoriere G
    Eur J Cancer; 2009 Sep; 45(13):2425-38. PubMed ID: 19643600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the TRAIL to therapeutic intervention in liver disease.
    Herr I; Schemmer P; Büchler MW
    Hepatology; 2007 Jul; 46(1):266-74. PubMed ID: 17596886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
    Kern MA; Haugg AM; Koch AF; Schilling T; Breuhahn K; Walczak H; Fleischer B; Trautwein C; Michalski C; Schulze-Bergkamen H; Friess H; Stremmel W; Krammer PH; Schirmacher P; Müller M
    Cancer Res; 2006 Jul; 66(14):7059-66. PubMed ID: 16849551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3.
    Abdollahi T; Robertson NM; Abdollahi A; Litwack G
    Cancer Res; 2003 Aug; 63(15):4521-6. PubMed ID: 12907626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
    J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression, cellular distribution, and prognostic relevance of TRAIL receptors in hepatocellular carcinoma.
    Kriegl L; Jung A; Engel J; Jackstadt R; Gerbes AL; Gallmeier E; Reiche JA; Hermeking H; Rizzani A; Bruns CJ; Kolligs FT; Kirchner T; Göke B; De Toni EN
    Clin Cancer Res; 2010 Nov; 16(22):5529-38. PubMed ID: 20889918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MSC(TRAIL)-mediated HepG2 cell death in direct and indirect co-cultures.
    Sun XY; Nong J; Qin K; Lu H; Moniri MR; Dai LJ; Warnock GL
    Anticancer Res; 2011 Nov; 31(11):3705-12. PubMed ID: 22110190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum response factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6.
    Farra R; Dapas B; Pozzato G; Giansante C; Heidenreich O; Uxa L; Zennaro C; Guarnieri G; Grassi G
    Biochimie; 2010 May; 92(5):455-63. PubMed ID: 20144681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A formulated red ginseng extract upregulates CHOP and increases TRAIL-mediated cytotoxicity in human hepatocellular carcinoma cells.
    Lee YS; Lee DG; Lee JY; Kim TR; Hong SS; Kwon SW; Kim YS
    Int J Oncol; 2013 Aug; 43(2):591-9. PubMed ID: 23708152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.